Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Animal Antibiotics and Antimicrobials Market Poised To Hit $8.03 Billion By 2030 With A 7.3% CAGR
The animal antibiotics and antimicrobials market has experienced strong growth in recent years. It is forecast to increase from $5.64 billion in 2025 to $6.05 billion in 2026, at a compound annual growth rate (CAGR) of 7.3%. The market’s expansion in the past can be attributed to a growing livestock population, a higher incidence of animal infectious diseases, the development of commercial animal farming, improvements in veterinary healthcare infrastructure, and the historical practice of using antibiotics for promoting growth.
The animal antibiotics and antimicrobials market is poised for significant expansion in the upcoming years, with projections indicating a rise to $8.03 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This expected increase throughout the forecast period stems from factors such as heightened regulations concerning antimicrobial resistance, a surging demand for secure animal-derived food products, a growing prevalence of companion animal ownership, increased funding in veterinary drug research and development, and the broadening scope of preventive animal healthcare strategies. Noteworthy trends for this period encompass the adoption of precision veterinary medicine, sustainable methods for livestock health management, digital systems for monitoring antimicrobial usage, AI-driven drug discovery for veterinary antibiotics, and intelligent manufacturing processes in veterinary pharmaceuticals.
Get A Free Sample Report With In-Depth Market Insights:
Animal Antibiotics and Antimicrobials Market Growth Backed By Core Demand Fundamentals
The increasing need for food items derived from animals is a primary factor propelling the expansion of the animal antibiotics and antimicrobials market. These animal-sourced foods, including milk, eggs, and meat, serve as significant nutritional sources and hold a vital position in the human diet. Entities engaged in producing animal-derived foods are prioritizing the creation of robust, disease-free animal populations by employing animal antibiotics and antimicrobials preventatively. A notable example is a report from June 2023, issued by the Food and Agriculture Organization (FAO), an Italy-based specialized agency of the United Nations, which forecasts a modest rise of 0.8 percent in global meat production for 2023, reaching 365 million tonnes (carcass weight equivalent) when contrasted with 2022 figures. Consequently, the growing appetite for animal-derived food products is anticipated to elevate the need for animal antibiotics and antimicrobials over the projected timeframe.
Animal Antibiotics and Antimicrobials Market Segmentation: How Does The Market Break Down By Category?
The animal antibiotics and antimicrobials market covered in this report is segmented –
1) By Type Of Product: Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Type Of Products
2) By Mode Of Delivery: Premixes, Oral Powder, Oral Solution, Injection, Other Modes Of Delivery
3) By Animal Type: Food-Producing Animals, Companion Animals
Subsegments:
1) By Tetracyclines: Oxytetracycline, Chlortetracycline, Doxycycline
2) By Penicillin: Penicillin G, Ampicillin, Amoxicillin
3) By Sulfonamides: Sulfadimidine, Sulfadiazine, Sulfamethoxazole
4) By Macrolides: Erythromycin, Tylosin, Tulathromycin
5) By Aminoglycosides: Gentamicin, Neomycin, Streptomycin
6) By Lincosamides: Lincomycin, Clindamycin
7) By Fluoroquinolones: Enrofloxacin, Marbofloxacin, Ciprofloxacin
8) By Cephalosporins: Cefquinome, Cephalexin, Cefoperazone
9) By Other Type Of Products: Nitrofurans, Phenicols
Animal Antibiotics and Antimicrobials Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the animal antibiotics and antimicrobials market are concentrating on developing inventive solutions, such as novel injectable multi-species treatments, to boost therapeutic effectiveness, simplify administration across diverse livestock species, and address the escalating need for effective disease management solutions amidst increasing concerns regarding animal health, productivity, and antimicrobial resistance. A novel injectable multi-species treatment refers to a newly developed injectable medication designed for safe and effective use across multiple animal species, including cattle, swine, sheep, or goats, rather than being confined to a single species. For instance, in February 2025, Elanco Animal Health Incorporated, a US-based animal health company, launched Pradalex (pradofloxacin injection), an innovative antibiotic specifically indicated for treating bovine respiratory disease (BRD) and swine respiratory disease (SRD), marking the first new molecule and injectable antibiotic for these indications approved by the U.S. FDA in roughly two decades. Pradalex’s unique mode of action provides comprehensive coverage against major BRD and SRD bacteria, delivers high therapeutic concentrations rapidly post-injection, and features an industry-leading withdrawal period. This combination enhances both efficacy and producer convenience while integrating seamlessly into farm-based disease management programs. This launch highlights how market participants are advancing antimicrobial therapies to tackle significant livestock health challenges, improve animal welfare, and support sustainable production systems.
Animal Antibiotics and Antimicrobials Market Competitive Overview And Top Companies
Major companies operating in the animal antibiotics and antimicrobials market are C. H. Boehringer Sohn AG & Co. KG, Zoetis Inc., Elanco Animal Health Inc., Merck & Co. Inc., Phibro Animal Health Corp., Ashish Life Science Pvt. Limited, Ayurvet Limited, Dechra Pharmaceuticals Plc, Huvepharma Inc., Inovet (V. M. D. nv/sa), Kyoritsu Seiyaku Corporation, Lutim Pharma Private Limited, Neogen Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., UCBVET Animal Health, Vetoquinol, Virbac, Zydus Animal Health Limited, China Animal Husbandry Co. Ltd., Norbrook Laboratories Limited, Biovet AD – Peshtera, Bio Agri Mix LP, Bioiberica S. A. U., Ceva Santé Animale
View The Full Animal Antibiotics and Antimicrobials Market Report:
Animal Antibiotics and Antimicrobials Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the animal antibiotics and antimicrobials market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal antibiotics and antimicrobials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
